Business Standard

Dr Reddy's Q1 net profit up 45% at Rs 663 cr on rise in generics business

A combination of factors, including an 8% growth in global generics business and the other operating income drove the growth in net profit of Dr Reddy's during the first quarter ended June, 2019

reddy, dr reddy's
Premium

Dr Reddy's laboratory

BS Reporter Hyderabad
Drug major Dr Reddy's Laboratories Limited has reported a 45.31 per cent jump in consolidated net profit at Rs 662.8 crore for the quarter ended June, 2019 as compared to Rs 456.1 crore in the same quarter previous year. 

The revenues of the company grew by 3 per cent to Rs 3,843.5 crore for the quarter under review, from Rs 3720.7 crore in the corresponding previous quarter

A combination of factors, including an 8 per cent growth in global generics business and the other operating income drove the growth in net profit of Dr Reddy's during the first quarter ended

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 29 2019 | 9:05 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com